1. Home
  2. APLS vs RNST Comparison

APLS vs RNST Comparison

Compare APLS & RNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLS
  • RNST
  • Stock Information
  • Founded
  • APLS 2009
  • RNST 1904
  • Country
  • APLS United States
  • RNST United States
  • Employees
  • APLS N/A
  • RNST N/A
  • Industry
  • APLS Biotechnology: Pharmaceutical Preparations
  • RNST Major Banks
  • Sector
  • APLS Health Care
  • RNST Finance
  • Exchange
  • APLS Nasdaq
  • RNST Nasdaq
  • Market Cap
  • APLS 3.5B
  • RNST 3.7B
  • IPO Year
  • APLS 2017
  • RNST N/A
  • Fundamental
  • Price
  • APLS $23.80
  • RNST $36.81
  • Analyst Decision
  • APLS Buy
  • RNST Buy
  • Analyst Count
  • APLS 20
  • RNST 6
  • Target Price
  • APLS $33.47
  • RNST $43.80
  • AVG Volume (30 Days)
  • APLS 2.3M
  • RNST 567.8K
  • Earning Date
  • APLS 11-04-2025
  • RNST 10-21-2025
  • Dividend Yield
  • APLS N/A
  • RNST 2.39%
  • EPS Growth
  • APLS N/A
  • RNST N/A
  • EPS
  • APLS N/A
  • RNST 2.24
  • Revenue
  • APLS $754,649,000.00
  • RNST $735,575,000.00
  • Revenue This Year
  • APLS $22.11
  • RNST $42.66
  • Revenue Next Year
  • APLS N/A
  • RNST $12.60
  • P/E Ratio
  • APLS N/A
  • RNST $16.46
  • Revenue Growth
  • APLS 20.02
  • RNST 17.23
  • 52 Week Low
  • APLS $16.10
  • RNST $26.97
  • 52 Week High
  • APLS $35.72
  • RNST $40.40
  • Technical
  • Relative Strength Index (RSI)
  • APLS 47.98
  • RNST 42.15
  • Support Level
  • APLS $21.07
  • RNST $36.01
  • Resistance Level
  • APLS $23.50
  • RNST $37.63
  • Average True Range (ATR)
  • APLS 0.80
  • RNST 0.80
  • MACD
  • APLS -0.03
  • RNST -0.17
  • Stochastic Oscillator
  • APLS 78.45
  • RNST 27.68

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

About RNST Renasant Corporation

Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has three reportable segments: Community banks, Insurance, and Wealth management. With its Community banks segment, the company provides a range of financial services to individuals and small businesses. Its Insurance segment is an insurance agency providing commercial and personal insurance through third-party carriers. The Wealth management segment provides a range of services, including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment.

Share on Social Networks: